Pharmacological evaluation of the stress-induced social avoidance model of anxiety

Brain Research Bulletin
Cs LevelekiJ Haller

Abstract

We have shown earlier that mild electric shocks induce a lasting social avoidance in male rats. Here we investigated whether shock-induced social avoidance can be developed into a laboratory model of stress-induced anxiety. The putative new model would assess sub-chronic, stress-induced anxiety (as opposed to tests based on natural fear) in a heterologous context (as opposed to classical fear conditioning). A single exposure to mild electric shocks induced a robust social avoidance that lasted more than 5 days. Low doses of chlordiazepoxide (0.5, 1 mg/kg), diazepam (0.5, 1, 5 mg/kg), buspirone (0.3, 1 mg/kg), and fluoxetine (1, 3, 5 mg/kg) abolished this effect, whereas the anxiogenic compound m-chlorophenylpiperazine (0.5-3 mg/kg) induced social avoidance in unshocked rats. These effects were produced at doses that did not affect locomotion in the open field. Haloperidol (0.05, 0.1, 1, 5 mg/kg) influenced social avoidance at sedative doses only. The sensitivity of the model to anxiolytic agents was compromised at high (sedating) doses. Taken conjointly, these data show that shock-induced social avoidance can be used to assess the anxiolytic potential of compounds. In addition to predictive validity, the model appears to show c...Continue Reading

References

Jan 1, 1978·British Journal of Pharmacology·S E File, J R Hyde
Jan 1, 1991·Behaviour Research and Therapy·B J CoxK Kuch
Sep 1, 1986·American Journal of Public Health·E L BassukA S Lauriat
Jan 1, 1971·Psychopharmacologia·J R VogelD E Clody
Aug 1, 1980·Pharmacology, Biochemistry, and Behavior·J Crawley, F K Goodwin
Oct 1, 1981·Pharmacology, Biochemistry, and Behavior·D TreitH C Fibiger
Sep 23, 1997·Behaviour Research and Therapy·M L Whittal, V L Goetsch
Dec 2, 1998·Behavioural Pharmacology·R J Rodgers
Aug 25, 2000·Psychopharmacology·J Haller, J Halász
Feb 28, 2001·The Psychiatric Clinics of North America·P V JettyA W Goddard
Apr 11, 2001·Psychological Reports·H D JohnsonM A Mahoney-Wernli
May 1, 2002·International Clinical Psychopharmacology·I Varia, F Rauscher
Aug 31, 2002·Psychopharmacology·Franco BorsiniDonatella Marazziti
Feb 26, 2003·European Journal of Pharmacology·D Caroline BlanchardRobert J Blanchard
May 29, 2003·Current Drug Targets. CNS and Neurological Disorders·Guy GriebelRégis Steinberg
Aug 30, 2003·Biological Psychiatry·Zul MeraliHymie Anisman
Jan 9, 2004·Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53·Christopher A KearneyCheryl A Tillotson
Jan 31, 2004·Pharmacology, Biochemistry, and Behavior·Matt W FeltensteinKenneth J Sufka
Feb 6, 2004·European Journal of Pharmacology·Shigeyuki ChakiThomas Steckler
May 1, 1951·Journal of Experimental Psychology·J S BROWNI E FARBER
Feb 20, 2004·Journal of Behavior Therapy and Experimental Psychiatry·Hendrik Hinrichsen, David M Clark
Apr 15, 2004·Neurochemistry International·Mariangela SerraGiovanni Biggio
Oct 12, 2004·Current Drug Targets·József HallerEszter Majercsik

❮ Previous
Next ❯

Citations

Nov 30, 2010·Bulletin of Experimental Biology and Medicine·D F AvgustinovichL A Koryakina
Jan 13, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Iulia TothDavid A Slattery
Dec 14, 2011·Current Opinion in Psychiatry·Jozsef Haller, Mano Alicki
Nov 19, 2008·BMC Neuroscience·Craig F FerrisNeal G Simon
Jul 2, 2008·Behavioural Brain Research·Hajnalka KompagneGyörgy Lévay
Feb 6, 2007·Pharmacology, Biochemistry, and Behavior·Grace Lee, Stephen C Gammie
Sep 18, 2012·Neuroscience and Biobehavioral Reviews·J HallerK Gyimesine Pelczer
Aug 17, 2005·Physiology & Behavior·Jacqueline BlundellPaul Burton
Nov 22, 2016·Journal of Neuroscience Research·Matia B Solomon
Jul 1, 2018·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Millie Rincón-CortésAnthony A Grace
May 13, 2017·Behaviour Research and Therapy·Namik KirlicRobin L Aupperle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here